Related Experiment Video

Updated: May 20, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Differential involvement of RalA and RalB in colorectal cancer

Timothy D Martin1, Channing J Der

  • 1Deparment of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Small Gtpases
|July 14, 2012
PubMed

Insights

KRAS-mutant colorectal cancer cells rely on RalA and RalB signaling for growth, but these proteins have opposing roles. This differs from pancreatic cancer, highlighting the need for tailored therapies targeting Ral signaling in different cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • K-Ras mutations drive oncogenesis through various downstream effectors.
  • The Ral guanine nucleotide exchange factor (RalGEF)-Ral pathway is increasingly recognized for its role in cancer.
  • Previous studies linked RalGEF-Ral pathway activation to KRAS-mutant pancreatic ductal adenocarcinoma (PDAC) tumorigenesis.

Purpose of the Study:

  • To investigate the necessity of Ral signaling for KRAS-mutant colorectal cancer (CRC) tumor cell growth.
  • To compare the roles of RalA and RalB in CRC with their known functions in PDAC.

Main Methods:

  • Analysis of RalA and RalB activation in CRC cell lines and tumors.
  • Assessment of RalA and RalB roles in CRC cell anchorage-independent growth.

Main Results:

  • Upregulated RalA and RalB activation was observed in CRC, similar to PDAC.
  • RalA and RalB exhibited antagonistic roles in regulating CRC cell anchorage-independent growth.
  • This contrasts with PDAC, where only RalA is essential for anchorage-independent growth.

Conclusions:

  • Ral signaling plays a crucial role in KRAS-mutant CRC growth.
  • Distinct roles of RalA and RalB in CRC versus PDAC necessitate cancer type-specific therapeutic strategies.
  • Targeted therapies for Ral signaling should be tailored for CRC and PDAC treatment.

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...